Eagle Bay Advisors
ABBV icon

Eagle Bay Advisors’s AbbVie ABBV Stock Holding History

Eagle Bay Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.22M Buy
8,494
+182
+2% +$46.7K 1.62% 17
2026
Q2 		$2.09M Buy
8,312
+81
+1% +$17.4K 1.57% 16
2026
Q1 		$1.79M Buy
8,231
+112
+1% +$24.8K 1.58% 17
2025
Q4 		$1.86M Sell
8,119
-409
-5% -$93.2K 1.35% 15
2025
Q3 		$1.97M Sell
8,528
-906
-10% -$184K 1.55% 14
2025
Q2 		$1.75M Sell
9,434
-48
-0.5% -$8.92K 1.45% 15
2025
Q1 		$1.99M Sell
9,482
-33
-0.3% -$6.42K 1.68% 14
2024
Q4 		$1.69M Sell
9,515
-206
-2% -$37.9K 1.06% 18
2024
Q3 		$1.92M Buy
9,721
+7
+0.1% +$1.31K 0.74% 28
2024
Q2 		$1.67M Buy
9,714
+378
+4% +$62.6K 1.01% 19
2024
Q1 		$1.7M Sell
9,336
-534
-5% -$92K 1.07% 19
2023
Q4 		$1.53M Sell
9,870
-385
-4% -$56.1K 0.97% 22
2023
Q3 		$1.53M Buy
10,255
+441
+4% +$64.7K 0.71% 31
2023
Q2 		$1.32M Sell
9,814
-22
-0.2% -$3.23K 0.76% 31
2023
Q1 		$1.57M Sell
9,836
-429
-4% -$65.6K 0.86% 26
2022
Q4 		$1.66M Sell
10,265
-1,233
-11% -$189K 0.93% 24
2022
Q3 		$1.54M Sell
11,498
-292
-2% -$41.9K 0.95% 21
2022
Q2 		$1.81M Buy
11,790
+329
+3% +$50.3K 1.09% 16
2022
Q1 		$1.86M Buy
11,461
+128
+1% +$18.6K 1.52% 13
2021
Q4 		$1.54M Sell
11,333
-2,476
-18% -$292K 0.98% 16
2021
Q3 		$1.49M Buy
13,809
+2,171
+19% +$248K 0.84% 20
2021
Q2 		$1.32M Buy
+11,638
New +$1.31M 1.07% 17

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Eagle Bay Advisors's ABBV Position: Q3 2026 in Review

Eagle Bay Advisors increased its AbbVie (ABBV) stake by 2.2% in Q3 2026, buying an estimated $46.7K and bringing the position to 8,494 shares worth $2.22M. The position accounts for 1.62% of the portfolio, ranked #17.

Eagle Bay Advisors first reported a position in ABBV in Q2 2021 and has held it in 22 quarters since. 1,551 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Eagle Bay Advisors held 8,494 shares of AbbVie worth $2.22M as of Q3 2026.
  • Eagle Bay Advisors bought 182 AbbVie shares in Q3 2026, an estimated $46.7K.
  • AbbVie made up 1.62% of Eagle Bay Advisors's portfolio in Q3 2026, its #17 holding.
  • Eagle Bay Advisors first reported a position in AbbVie in Q2 2021 and has held it in 22 quarters since.
  • 1,551 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Eagle Bay Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.